Cantor Fitzgerald & Co.

Cantor Fitzgerald & Co.

Cantor Fitzgerald & Co.

Date Founded


Type of Company


Employees (Worldwide)

1,001 - 5,000


Investment Banking & Brokerage
Other Business & Consulting Services
Market & Policy Research
IT Consulting & Services
Accounting & Financial Services
Investment Services & Portfolio Management

Company Description

Cantor Fitzgerald is a leading global financial services firm at the forefront of financial and technological innovation. It is a preeminent capital markets investment bank serving more than 5,000 institutional clients around the world. Cantor Fitzgerald & Co. is one of 21 primary dealers authorized to trade U.S. government securities with The Federal Reserve Bank of New York. Cantor Fitzgerald's 1,600 employees serve clients through over 30 locations, including major financial centers around the world in the Americas, Europe, Asia/Pacific, and the Middle East.

Contact Data
Trying to get in touch with decision makers at Cantor Fitzgerald & Co.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees


Head of Investment Banking

Paths to Cantor Fitzgerald & Co.
Potential Connections via
Relationship Science
Cantor Fitzgerald & Co.
Recent Transactions
Details Hidden

Fennec Pharmaceuticals, Inc. issued USD Common Shares

Details Hidden

Symphony Innovation LLC purchases TeraRecon, Inc.

Details Hidden

Pivotal Acquisition Corp. purchases LDiscovery LLC from The Carlyle Group LP (Corporate Private Equity), WestView Capital Management Co., Inc., Revolution Capital

Transaction Clients
Investment Advisor

Advised on Nasdaq, Inc. purchases BGC Partners, Inc. /US Treasury Electronic Trading Ops from BGC Partners, Inc.

Investment Advisor

Advised on Hooper Holmes, Inc. purchases Accountable Health Solutions LLC from Principal Financial Group, Inc.


Advised on Pacific Biosciences of California, Inc. issued . USD Common Stock

Transaction Advisors
Legal Advisor

Advised onAbeona Therapeutics, Inc. issued USD Common Stock

Legal Advisor

Advised onHRG Group, Inc. issued USD Common Stock

Legal Advisor

Advised onHeron Therapeutics, Inc. issued USD Common Stock

Legal Advisor

Advised onGalmed Pharmaceuticals Ltd. issued USD Ordinary Shares

Legal Advisor

Advised onSynergy Pharmaceuticals LLC issued . USD Common Stock

Legal Advisor

Advised onHaymaker Acquisition Corp. issued USD Units Consisting of Common Stock and Warrants

Advisors & Consultants
Legal Advisor

Co-Chair, Banking & Leveraged Finance Group at Bingham McCutchen LLP

Legal Advisor

Of Counsel at Paul, Weiss, Rifkind, Wharton & Garrison LLP

Legal Advisor

Partner at Goodwin Procter LLP


CoPERA's trust funds are invested under the direction of a board of trustees. Their investment strategy uses actuarially established asset allocation investment objectives with long-term goals and policies. Assets are diversified into domestic and international stocks, corporate, government, and international bonds, mortgages, real estate and alternative investments. The fund is long-term in nature and the selection of investments is regulated by statutory limitation, investment time horizon, the limits of acceptable risk and the objective of optimizing the total rate of return. The targeted strategic asset allocation is designed to provide an optimal diversification to reduce risk and maximize total rate of return relative to risk. Many of CoPERA's actively managed portfolios are managed by outside sub-advisors.

Political Donations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cantor Fitzgerald & Co.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cantor Fitzgerald & Co.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cantor Fitzgerald & Co..